Citadel Advisors’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,856
| Closed | -$57.6K | – | 6441 |
|
|
2024
Q1 | $57.6K | Sell |
15,856
-13,705
| -46% | -$49.7K | ﹤0.01% | 5286 |
|
|
2023
Q4 | $37K | Buy |
+29,561
| New | +$37K | ﹤0.01% | 5220 |
|
|
2023
Q1 | – | Sell |
-18,674
| Closed | -$45.8K | – | 6269 |
|
|
2022
Q4 | $45.8K | Sell |
18,674
-6,200
| -25% | -$15.2K | ﹤0.01% | 5302 |
|
|
2022
Q3 | $61K | Sell |
24,874
-3,014
| -11% | -$7.39K | ﹤0.01% | 5258 |
|
|
2022
Q2 | $83K | Buy |
+27,888
| New | +$83K | ﹤0.01% | 5360 |
|
|
2021
Q2 | – | Sell |
-14,915
| Closed | -$84K | – | 6773 |
|
|
2021
Q1 | $84K | Buy |
+14,915
| New | +$84K | ﹤0.01% | 5929 |
|